Anna Rita Bellu

668 total citations
18 papers, 537 citations indexed

About

Anna Rita Bellu is a scholar working on Molecular Biology, Genetics and Epidemiology. According to data from OpenAlex, Anna Rita Bellu has authored 18 papers receiving a total of 537 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 6 papers in Genetics and 5 papers in Epidemiology. Recurrent topics in Anna Rita Bellu's work include Virus-based gene therapy research (6 papers), Autophagy in Disease and Therapy (5 papers) and Peroxisome Proliferator-Activated Receptors (5 papers). Anna Rita Bellu is often cited by papers focused on Virus-based gene therapy research (6 papers), Autophagy in Disease and Therapy (5 papers) and Peroxisome Proliferator-Activated Receptors (5 papers). Anna Rita Bellu collaborates with scholars based in Netherlands, Italy and Finland. Anna Rita Bellu's co-authors include Jan A.K.W. Kiel, Marten Veenhuis, Hidde J. Haisma, Ida J. van der Klei, Masayuki Komori, Josée A. Plantinga, Florian A. Salomons, Marianne G. Rots, Jan A. A. M. Kamps and Marije Boesjes and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Controlled Release and International Journal of Pharmaceutics.

In The Last Decade

Anna Rita Bellu

18 papers receiving 531 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anna Rita Bellu Netherlands	11	385	191	122	54	53	18	537
Josh Lewis Stern United States	14	509 1.3×	220 1.2×	74 0.6×	98 1.8×	49 0.9×	17	942
Tom C. Tsang United States	15	287 0.7×	53 0.3×	96 0.8×	131 2.4×	34 0.6×	32	578
Lisa G. van den Hengel Netherlands	9	257 0.7×	99 0.5×	35 0.3×	27 0.5×	63 1.2×	10	527
Cheng‐Po Hu Taiwan	16	283 0.7×	217 1.1×	64 0.5×	182 3.4×	39 0.7×	27	699
Shweta Tyagi India	13	514 1.3×	74 0.4×	77 0.6×	78 1.4×	79 1.5×	26	768
Kiyomasa Oka Japan	14	253 0.7×	102 0.5×	44 0.4×	89 1.6×	101 1.9×	24	455
Erik Vernet Denmark	9	278 0.7×	71 0.4×	30 0.2×	51 0.9×	38 0.7×	17	405
Siamak A. Kamranvar Sweden	11	229 0.6×	179 0.9×	66 0.5×	334 6.2×	49 0.9×	15	625
Elisa Palumbo Italy	11	271 0.7×	106 0.6×	71 0.6×	49 0.9×	17 0.3×	21	459
Senta M. Kapnick United States	15	218 0.6×	111 0.6×	71 0.6×	81 1.5×	43 0.8×	22	611

Countries citing papers authored by Anna Rita Bellu

Since Specialization

Citations

This map shows the geographic impact of Anna Rita Bellu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Rita Bellu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Rita Bellu more than expected).

Fields of papers citing papers by Anna Rita Bellu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Rita Bellu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Rita Bellu. The network helps show where Anna Rita Bellu may publish in the future.

Co-authorship network of co-authors of Anna Rita Bellu

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Rita Bellu. A scholar is included among the top collaborators of Anna Rita Bellu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Rita Bellu. Anna Rita Bellu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

1.

Ásgeirsdóttir, Sigrídur A., Peter J. Zwiers, Anna Rita Bellu, et al.. (2012). Targeted adenovirus mediated inhibition of NF-κB-dependent inflammatory gene expression in endothelial cells in vitro and in vivo. Journal of Controlled Release. 166(1). 57–65. 13 indexed citations

2.

Haisma, Hidde J., et al.. (2010). Selective targeting of adenovirus to αvβ3 integrins, VEGFR2 and Tie2 endothelial receptors by angio-adenobodies. International Journal of Pharmaceutics. 391(1-2). 155–161. 17 indexed citations

3.

Bax, Noortje A.M., Anna Rita Bellu, Elizabeth M. Winter, et al.. (2010). Epicardium-derived cells enhance proliferation, cellular maturation and alignment of cardiomyocytes. Journal of Molecular and Cellular Cardiology. 49(4). 606–616. 62 indexed citations

4.

Haisma, Hidde J. & Anna Rita Bellu. (2010). Pharmacological Interventions for Improving Adenovirus Usage in Gene Therapy. Molecular Pharmaceutics. 8(1). 50–55. 19 indexed citations

5.

Haisma, Hidde J., Marije Boesjes, Barry W. A. van der Strate, et al.. (2009). Scavenger Receptor A: A New Route for Adenovirus 5. Molecular Pharmaceutics. 6(2). 366–374. 66 indexed citations

6.

Haisma, Hidde J., et al.. (2008). Polyinosinic acid enhances delivery of adenovirus vectors in vivo by preventing sequestration in liver macrophages. Journal of General Virology. 89(5). 1097–1105. 60 indexed citations

7.

Haisma, Hidde J., et al.. (2007). Poly I prevents adenoviral vector clearance by Kupffer cells and increases efficiency in gene therapy applications. Human Gene Therapy. 18(10). 981–982. 2 indexed citations

8.

Roy, Himadri, Shalini Bhardwaj, Mohan Babu, et al.. (2005). Adenovirus-Mediated Gene Transfer of Placental Growth Factor to Perivascular Tissue Induces Angiogenesis via Upregulation of the Expression of Endogenous Vascular Endothelial Growth Factor-A. Human Gene Therapy. 16(12). 1422–1428. 54 indexed citations

9.

Roy, Himadri, Shalini Bhardwaj, Mohan Babu, et al.. (2005). Adenovirus-Mediated Gene Transfer of Placental Growth Factor to Perivascular Tissue Induces Angiogenesis via Upregulation of the Expression of Endogenous Vascular Endothelial Growth Factor-A. Human Gene Therapy. 0(0). 3952089601–3952089601. 2 indexed citations

10.

Bellu, Anna Rita, et al.. (2004). Cold-inducible selective degradation of peroxisomes in. FEMS Yeast Research. 5(3). 281–285. 1 indexed citations

11.

Bellu, Anna Rita & Jan A.K.W. Kiel. (2003). Selective degradation of peroxisomes in yeasts. Microscopy Research and Technique. 61(2). 161–170. 47 indexed citations

12.

Berardi, Enrico, et al.. (2003). ALG2, the Hansenula polymorpha isocitrate lyase gene. Yeast. 20(9). 803–811. 5 indexed citations

13.

Bellu, Anna Rita, Florian A. Salomons, Jan A.K.W. Kiel, Marten Veenhuis, & Ida J. van der Klei. (2002). Removal of Pex3p Is an Important Initial Stage in Selective Peroxisome Degradation in Hansenula polymorpha. Journal of Biological Chemistry. 277(45). 42875–42880. 70 indexed citations

14.

Bellu, Anna Rita, Masayuki Komori, Ida J. van der Klei, Jan A.K.W. Kiel, & Marten Veenhuis. (2001). Peroxisome Biogenesis and Selective Degradation Converge at Pex14p. Journal of Biological Chemistry. 276(48). 44570–44574. 88 indexed citations

15.

Bellu, Anna Rita, Anita M. Kram, Jan A.K.W. Kiel, Marten Veenhuis, & Ida J. van der Klei. (2001). Glucose-induced and nitrogen-starvation-induced peroxisome degradation are distinct processes inHansenula polymorphathat involve both common and unique genes. FEMS Yeast Research. 1(1). 23–31. 21 indexed citations

16.

Bellu, Anna Rita, et al.. (2001). Glucose-induced and nitrogen-starvation-induced peroxisome degradation are distinct processes in that involve both common and unique genes. FEMS Yeast Research. 1(1). 23–31. 2 indexed citations

17.

Bellu, Anna Rita, et al.. (1999). Characterization of theHansenula polymorpha CPY gene encoding carboxypeptidase Y. Yeast. 15(3). 181–189. 7 indexed citations

18.

Bellu, Anna Rita, et al.. (1999). Characterization of the Hansenula polymorpha CPY gene encoding carboxypeptidase Y. Yeast. 15(3). 181–189. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact